Upon receipt at our post market quality assurance laboratory a thorough product analysis was performed.Review of the device memory confirmed several atrial tachycardia response episodes.Three faults occurred within approximately five minutes of each other; therefore, the device automatically enters safety mode.The device was taken out of safety mode and the device reverted to primary operation.The device was then exposed to simulated heart load conditions, and the pacing, and sensing functions were tested.Impedance testing was completed and all measurements were within normal limits.The device operated appropriately with no interruptions in therapy output at the returned programmed settings.A series of electrical tests was also performed, and again, normal device function was observed.As a result, analysis confirmed the clinical observations.
|
Boston scientific received information that the patient with this device had atrial flutter.When the physician attempted to stimulate faster than the atrial flutter, the overstimulation resulted in the device indicating safety mode.As a result, a device replacement was scheduled.This device was explanted and replaced.The two competitor leads were also removed from service.No additional adverse patient effects were reported.
|